Therefore, the inclusion of more functional data to evaluate this will certainly deepen our understanding of the molecular bases of the yin and yang-like behavior of the CDKN2A/B deletions in ALL. The gene discussed is CDKN2A; the disease is acute lymphoblastic leukemia.